Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
scientific article
Author/s
author: Andrea Sartore-Bianchi, Livio Trusolino, Cosimo Martino, Sara Lonardi, Francesca Bergamo, Vittorina Zagonel, Francesco Leone, Ilaria Depetris, Giulia Siravegna, Valter Torri, A Amatu, Angelo Vanzulli, Daniele Regge, Silvio Marco Veronese, Paolo M. Comoglio, Alberto Bardelli, Silvia Marsoni, Salvatore Siena, Andrea Bertotti, Katia Bencardino, Patrizia Racca, Calogero Lauricella
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.